Protective effect of excretory-secretory proteins from Trichinella spiralis muscle larvae against myocardial injury in septic mice.
10.12122/j.issn.1673-4254.2022.06.05
- Author:
Yuan YUAN
1
;
Feng NIAN
2
;
Hui Hui LI
3
;
Hui Juan YANG
4
;
Yu Zhi WU
5
;
Meng Xi MA
5
;
Kai Gui WANG
5
;
Xue Ling CHEN
5
;
Zi Qiang ZHANG
5
;
Gen LI
5
;
Xiao Di YANG
6
;
Qiang WU
7
Author Information
1. Department of Human Anatomy, Bengbu Medical College, Bengbu 233000, China.
2. Department of Oncology, Bengbu Third People's Hospital Affiliated to Bengbu Medical College, Bengbu 233000, China.
3. Department of Histology and Embryology, Bengbu Medical College, Bengbu 233000, China.
4. Department of Nephrology, Bengbu Medical College, Bengbu 233000, China.
5. Immunology Experiment Center, Bengbu Medical College, Bengbu 233000, China.
6. Department of Pathogen Biology, Bengbu Medical College, Bengbu 233000, China.
7. Department of Intensive Care Medicine, First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China.
- Publication Type:Journal Article
- Keywords:
Trichinella spiralis;
excretory-secretory proteins;
sepsis myocardial injury
- MeSH:
Animals;
Cytokines;
Dexamethasone;
Heart Injuries;
Interleukin-10;
Interleukin-6;
Larva;
Male;
Mice;
Mice, Inbred BALB C;
Myocardium;
Sepsis;
Transforming Growth Factor beta;
Trichinella spiralis;
Tumor Necrosis Factor-alpha
- From:
Journal of Southern Medical University
2022;42(6):824-831
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the protective effect of excretory-secretory proteins from Trichinella spiralis muscle larvae (Ts-MES) on sepsis-induced myocardial injury in mice.
METHODS:Eighty male BALB/C mice were randomized equally into sham-operated group, myocardial injury group, Ts-MES treatment group and dexamethasone treatment group. In the latter 3 groups, sepsis-induced myocardial injury models were established by cecal ligation and perforation; the sham operation was performed by exposure of the cecum without ligation or perforation. Forty minutes after the operation, the mice were given intraperitoneal injections 150 μL PBS, 20 μg TS-MES or 0.3 mg/kg dexamethasone as indicated. At 12 h after the operation, 6 mice were randomly selected from each group for echocardiography, and 8 mice were used for observing the survival rate within 72 h. The remaining 6 mice were examined for myocardial pathologies with HE staining and serum levels of NTPro-BNP and cTnI with ELISA; the expressions of TNF-α, IL-6, IL-10 and TGF-β in the serum and myocardial tissue were detected using ELISA and qRT-PCR.
RESULTS:Compared with the sham-operated mice, the septic mice showed significantly decreased cardiac function indexes (LVEF, LVFS, and E/A) with lowered survival rate within 72 h (P < 0.001) and significantly higher myocardial injury scores and serum levels of NTPro-BNP and cTnI (P < 0.01). Treatment with TS-MES significantly improved the cardiac function and 72-h survival rate (P < 0.05) and lowered the myocardial injury scores and serum levels of NTPro-BNP and cTnI (P < 0.05) in the septic mice. Compared with the sham-operated mice, the septic mice had obviously increased TNF-α and IL-6 levels in the serum and myocardial tissue (P < 0.001), which were significantly lowered by treatment with TS-MES (P < 0.05). TS-MES and dexamethasone both increased the levels of IL-10 and TGF-β in the septic mice, but the changes were significant only in TS-MES-treated mice (P < 0.05).
CONCLUSION:Ts-MES are capable of protecting against myocardial injury in septic mice by reducing the production of pro-inflammatory cytokines and enhancing the levels of regulatory cytokines.
